United States: Long-Expected Omnibus Hipaa Rule Implements Significant Privacy And Security Regulations For Entities And Business Associates

Keywords: Health and Human Services, Privacy, Security, HIPAA,

On January 17, 2013, the Department of Health and Human Services (HHS) issued the final "omnibus" rule modifying the HIPAA Privacy, Security, Breach Notification and Enforcement Rules (Final Rule).1 As expected, the Final Rule extends the reach and limits of HIPAA's privacy and security provisions. The Final Rule implements mandated changes to HIPAA set forth by the Health Information Technology for Economic and Clinical Health Act (the HITECH Act), enacted February 17, 2009, and, to a lesser extent, the Genetic Information Nondiscrimination Act of 2008 (GINA).

The Final Rule becomes effective on March 26, 2013, with covered entities and business associates expected to comply with the new standards and implementation specifications by September 23, 2013 (180 days from the effective date).

As described in more detail below, the Final Rule expands certain HIPAA obligations to business associates and their subcontractors, modifies the breach notification standard, clarifies the civil monetary penalty structure and implements a variety of other provisions.

Business Associates

One of the most significant sections of the Final Rule relates to business associates of covered entities. The Final Rule broadens the definition of "business associate" to implement changes made under the HITECH Act, to conform to the provisions of the Patient Safety and Quality Improvement Act of 2005 (PSQIA), and to provide greater clarity to persons with access to protected health information generally.

A business associate now includes "a[ny] person who 'creates, receives, maintains or transmits' protected health information on behalf of a covered entity." (emphasis added). Specifically, the Final Rule identifies the following as business associates: patient safety organizations, health information entities, e-prescribing gateways and other contractors and subcontractors that provide data transmission services or facilitate access to protected health information (PHI). Subcontractors also now fall within the definition of business associate for whom covered entities ultimately will be responsible under the HIPAA Privacy Rule and Security Rule (the HIPAA Rules).

The Final Rule provides the following guidance concerning business associate agreements:

  • Vendors that contract with a covered entity to offer personal health records to patients on behalf of the covered entity are business associates and must enter into a written business associate agreement or similar arrangement with the covered entity.
  • Vendors that provide data transmission services to a covered entity that require access to PHI on a routine basis, regardless of whether such PHI is actually accessed by the vendors, are business associates and must enter into a written business associate agreement or similar arrangement with the covered entity.
  • Vendors with transient access to PHI and that act as mere conduits with regard to the transmission of PHI (e.g., the US Postal Service or Internet service providers) are not business associates and, as a result, a business associate agreement is not required.
  • Vendors that provide storage services with respect to PHI and have access to such PHI are business associates with which the covered entity should enter into a contractual relationship regarding such PHI.
  • A covered entity is not required to have a contractual relationship with its business associates' subcontractors. Instead, covered entities should obtain "satisfactory assurances required by the [HIPAA] Rules from their business associates." Business associates are required to enter into business associate agreements with those subcontractors that will be creating or receiving PHI on behalf of the business associates. Agreements must be written with a subcontractor's subcontractors "no matter how far 'down the chain' the information flows."

As a practical matter, the expansion of the definition of business associates likely will have limited impact on existing contractual relationships between covered entities and business associates. To the extent existing agreements lack such provisions, they can be amended to meet the expanded definition.

In addition, per the HITECH Act, the Final Rule also expands the applicability of the HIPAA Rules to business associates. For example, the Security Rule's administrative, physical, and technical safeguard requirements and documentation requirements now apply directly to business associates. HHS states that the extension of direct liability for compliance with the Security Rule is largely ministerial, as the Security Rule currently requires that covered entities establish business associate agreements that require the implementation of such safeguards. As a result, business associates and subcontractors should already have such security practices in place.

Similarly, the Final Rule makes business associates directly liable under the Privacy Rule for "uses and disclosures of [PHI] that are not in accord with its business associate agreement or the Privacy Rule." Moreover, business associates will also be directly liable under the Privacy Rule for failure to enter into business associate agreements with any subcontractors.

Breach Notification

In 2009, HHS issued an interim final rule to implement the breach notification provisions of the HITECH Act. Under the interim final rule, if a covered entity or business associate believed that an "unauthorized acquisition, access, use or disclosure of protected health information" had occurred, then, in order to determine whether such use or disclosure was a breach, the covered entity or business associate had to perform a comprehensive risk assessment to determine the likelihood that an individual would suffer harm as a result of such use or disclosure.

Unlike the interim final rule - in which the risk assessment was based on harm to an individual - the Final Rule presumes that any unauthorized access of PHI is a breach and requires that the risk assessment focus on the likelihood that the PHI has been compromised. If a covered entity or business associate that has suffered a breach can demonstrate that there is a "low probability" that the PHI has been compromised, notification may not be required. This "low probability" determination will be based on a risk assessment that includes the following four factors:

  • The nature and extent of PHI involved, including the types of identifiers and likelihood of re-identification;
  • The unauthorized person who used the PHI or to whom the disclosure of PHI was made;
  • Whether the PHI was actually viewed or acquired or, alternatively, if only the opportunity existed for the information to be viewed or acquired; or
  • The extent to which the risk to the PHI has been mitigated.

With regard to a business associate's notification obligations to a covered entity, the Final Rule establishes that a business associate must provide notice of breach of unsecured PHI to a covered entity "without unreasonable delay and in no case later than 60 days following the discovery of a breach."

With respect to notification to affected individuals of a breach, where a business associate is acting as an agent of the covered entity, discovery of a potential breach by the business associate is imputed to the covered entity. As a result, the covered entity will be required to provide notifications based on when the business associate discovers the breach and not when the business associate notifies the covered entity. HHS recommends that covered entities who have an agency relationship with their business associates address such issues in their business associate agreements.

Civil Monetary Penalties

The Final Rule's section on civil monetary penalties, while expected based on past rulemaking, is nevertheless noteworthy. On October 30, 2009, HHS issued an interim final rule that would revise HIPAA's enforcement provisions to incorporate the range of potential civil money penalty amounts set forth in section 13410(d) of the HITECH Act .

Prior to the HITECH Act, HIPAA's enforcement provisions authorized a civil penalty of not more than $100 for each violation, with the total amount imposed on a covered entity for all violations of an identical nature during a calendar year not to exceed $25,000. The HITECH Act instead imposed a tiered system featuring increasing penalty amounts for violations based on increasing levels of culpability associated with each tier. The Final Rule adopts the HITECH Act's tiered system. This tiered structure and corresponding penalties will apply to violations by covered entities and business associates.

Under the Final Rule, the tiered penalty scheme will be applicable to violations occurring on or after February 18, 2009. The penalty scheme is as follows, as summarized by the table published by HHS and copied here:

  • For violations in which the covered entity did not know and, by exercising reasonable diligence, would not have known that the covered entity violated a provision, an amount not less than $100 or more than $50,000 for each violation;
  • For a violation that was due to a reasonable cause, and not to willful neglect, an amount not less than $1000 or more than $50,000 for each violation;
  • For a violation that was due to willful neglect and was timely corrected, an amount not less than $10,000 or more than $50,000 for each violation; and
  • For a violation that was due to willful neglect and was not timely corrected, an amount not less than $50,000 for each violation.

The Final Rule sets a cap in that any penalty for violations of the same requirement or prohibition under any of the above categories may not exceed $1.5 million in a calendar year.

Categories of Violations and Respective Penalty Amounts Available

The maximum penalty will not be imposed for every violation. Instead, HHS has identified five categories that it will consider on a case-by-case basis in determining the amount of any civil money penalty. The Final Rule expanded these categories to include the following parameters. These will be fact-specific inquiries.

  • The nature and extent of any violation, including the number of individuals affected and the duration of the violation;
  • The nature and extent of any individual's resulting physical, financial, or reputational harm, including any hindrance to the individual's ability to obtain health care;
  • The history of prior noncompliance, including similar prior indications of noncompliance and the offending party's responses to them, and also history of compliance;
  • The financial condition of the offending party, including difficulties that could have affected compliance or that could cause a money penalty to jeopardize the future provision of health care; and
  • Such other matters as justice may require.

The Final Rule also limits the affirmative defenses available to an entity that violates HIPAA. A complete defense is available only if the violation was not due to willful neglect and was corrected within 30 days of when the entity knew, or by exercising "reasonable diligence" would have known, of the violation. This means that an entity's reasonable lack of knowledge of a violation alone will no longer constitute a complete defense, unless, in certain circumstances, it is timely corrected. Moreover, an employee or business associate's knowledge of a violation may be imputed to a covered entity. Finally, the HHS Secretary can waive the penalty to the extent that payment of the penalty would be excessive relative to the violation, and it is also within the Secretary's discretion to settle any issue or case.

Other Notable Components

The following section describes other notable provisions of the Final Rule.

Unsecured PHI. The Final Rule defines "unsecured PHI" to mean "protected health information that is not rendered unusable, unreadable, or indecipherable to unauthorized individuals through the use of a technology or methodology specified by the Secretary in guidance." Covered entities that implement the specified technologies and methodologies with respect to PHI are not required to provide notifications in the event of a breach of such information - that is, the information is not considered "unsecured" in such cases. The Secretary's guidance referenced in the Final Rule is guidance that was issued on April 19, 2009, which lists and describes "encryption" and "destruction" as the two technologies accepted.2

Fundraising The Final Rule expands the types of PHI that may be used (without the need for an authorization) for fundraising purposes. The additional types of PHI include date of birth, general department of service (e.g., cardiology), treating physician information, and outcome information. In addition, covered entities must provide a clear and conspicuous method for opting out of fundraising communications and the method must not result in undue burden or more than nominal cost to the individual.

Marketing. The Final Rule expands the uses of PHI that are considered to be marketing and, therefore, require an authorization. The Final Rule requires authorization for all treatment and health care operation communications that encourage the use of a product or service when a covered entity receives "financial remuneration" for making the communication from the third party whose product or service is being marketed.

Sale of PHI. The Final Rule defines sale of PHI as "a disclosure of [PHI] by a covered entity or business associate, if applicable, where the covered entity or business associate directly or indirectly receives remuneration from or on behalf of the recipient of the [PHI] in exchange for the [PHI]." Under the Final Rule, a covered entity must obtain an authorization for any disclosure of PHI that constitutes a sale of PHI.

Research. The Final Rule finalizes the HHS proposal to allow a blending of "conditioned" and "unconditioned" authorizations in a single document. Accordingly, HIPAA does not allow a covered entity to condition treatment on an individual executing an authorization. One of the exceptions is for clinical research, where the covered entity may condition the researchrelated treatment on execution of an authorization to use and disclose the individual's PHI in the research.

State Preemption. Although the Final Rule adopts preemption language to the extent that it can under previous proposals and rules under HIPAA and the HITECH Act, it can only preempt state law to the extent those laws are contrary to and more stringent than the Final Rule, as "Congress made it clear" that was its intention. Without further action from Congress, uniformity as to the various privacy laws will not be possible through rulemaking.

GINA. The Final Rule, in accordance with GINA, clarifies that genetic information is a type of health information and generally prohibits health plans from using or disclosing genetic information for underwriting purposes. "Genetic information" is broadly defined to include manifestation of a disease or disorder in a family member of an individual in addition to genetic tests of individuals and family members and requests for and receipt of genetic services. Other than clarifying that genetic information is health information, the provision does not impact health care providers.

Notices of Privacy Practices. Providers will need to update their Notice of Privacy Practices. They should advise individuals of the Final Rule's required changes, such as the duty of a covered entity to notify affected individuals of a breach of unsecured PHI and ensure that the Notice accurately describes privacy practices changes.

Forms. The Final Rule states that further educational materials and guidance can be found on its website at http://www.hhs.gov/ocr/ privacy/hipaa/understanding/index.html . Further, HHS has posted on its website sample business associate agreement provisions to help covered entities and business associates comply with the new business associate agreement requirements under the Final Rule.3


1 Available at http://www.ofr.gov/ OFRUpload/OFRData/2013-01073_PI.pdf .

2 See 75 Fed. Reg. 19006.

3 Available at http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/contractprov.html .

Previously published on February 11, 2013.

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2013. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions